B+
Bull case
20%
Probability
Target price
$1.60
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
PHIO
PhioCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The completed PH-762 drug-substance batch removes one manufacturing hurdle. Favorable FDA feedback and on-time clinical supplies could support Phase 2b initiation [#PR-2026-09-14] [#8-K-2026-10-13].
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
Cash burn and potential ATM issuance create dilution risk [#PR-EARNINGS-2026-08-06].
Momentum
87
Value
58
Sentiment
47
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.80 · Bull $1.60 · Bear $0.30Analysis 2026-10-20; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-20 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $14.00
Why
Momentum87 · Δ7d -
Value58 · Δ7d -0.2
Sentiment47 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.2.
Contradictions & invalidation
- • Cash burn and potential ATM issuance create dilution risk [#PR-EARNINGS-2026-08-06].
- • Drug-product completion and remaining nonclinical work are not yet confirmed complete [#PR-2026-09-14] [#PR-2026-10-13].
- • Phase 2b has not begun, FDA feedback is unconfirmed, and additional development work or financing could delay progress or dilute holders.
Catalyst clock
2026-12-31
FDA feedback on PH-762 Phase 2b design
Lead driver: Value · See fundamentals
Momentum
87
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
47% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-0.5
Sentiment
47
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 86.7 / Value 58.0 / Sentiment 46.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-20. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.80
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.30
Analysis reference price unavailable
Analysis 2026-10-20 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$9.9M
Beta
0.93
Shares Out
11.62M
P/E (TTM) · Derived
-0.6
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.68
Rev YoY
-100.0%
EPS YoY
-21.1%
Gross Margin
-
Op Margin
-
Net Debt
-$21.03M
Current Ratio
8.39
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data